Nile Pharmaceuticals and Chemical Industries Company (EGX:NIPH)

Market Cap	16.75B +393.0%
Revenue (ttm)	2.13B +65.5%
Net Income	256.37M +103.9%
EPS	5.13 +22.3%
Shares Out	50.00M
PE Ratio	65.34
Forward PE	n/a
Dividend	2.00 (0.60%)
Ex-Dividend Date	Nov 25, 2026

Volume	492,956
Open	325.01
Previous Close	325.01
Day's Range	325.25 - 338.50
52-Week Range	87.00 - 516.96
Beta	0.71
Analysts	n/a
Price Target	n/a
Est. Earnings	Nov 19, 2026

About EGX:NIPH

Nile Pharmaceuticals and Chemical Industries Company develops, produces, and sells pharmaceutical products in Egypt. The company offers manufacturing, research and development, training, and biotechnology solutions. It also exports its products to the countries in the Middle East. Nile Pharmaceuticals and Chemical Industries Company was founded in 1962 and is based in Cairo, Egypt.

• Industry: Pharmaceutical Preparations
• Founded: 1962
• Employees: 2,500
• Stock Exchange: Egyptian Stock Exchange
• Ticker Symbol: NIPH

Financial Performance

In fiscal year 2026, EGX:NIPH's revenue was 2.13 billion, an increase of 65.48% compared to the previous year's 1.29 billion. Earnings were 256.37 million, an increase of 103.91%.

Data Source: S&P Global Market Intelligence

Fundamental and historical data is provided by S&P Global Market Intelligence.

Last checked:

Nov 14, 2026

Data Sources Report a data error